ruthenium chloride (rucl3) has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Caldeira, RP; Correa, RS; da Silva, PFF; de Silveira-Lacerda, EP; Martins-Oliveira, A; Mello-Andrade, F; Pires, WC; Teixeira, T; Travassos, IO | 1 |
| Bergamo, A; Sava, G | 1 |
| Ando, A; Ando, I; Hiraki, T; Hisada, K | 1 |
1 review(s) available for ruthenium chloride (rucl3) and Experimental Neoplasms
| Article | Year |
|---|---|
Ruthenium-based compounds and tumour growth control (review).
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Neoplasms, Experimental; Ruthenium Compounds; Ruthenium Red; Solvents | 2000 |
2 other study(ies) available for ruthenium chloride (rucl3) and Experimental Neoplasms
| Article | Year |
|---|---|
Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets.
Topics: Allopurinol; Animals; Antineoplastic Agents; Ascitic Fluid; Cell Cycle; Cell Migration Assays; Cell Survival; Cells, Cultured; Female; Fibroblasts; Humans; Mammary Neoplasms, Animal; Mice; Neoplasms, Experimental; Ruthenium Compounds | 2021 |
Distribution of 103Ru-chloride in tumor-bearing animals and the mechanism for accumulation in tumor and liver.
Topics: Animals; Liver; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Rats; Ruthenium; Ruthenium Compounds; Ruthenium Radioisotopes; Tissue Distribution | 1988 |